Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Dennis W. Raisch"'
Autor:
Cheng Chen, Melissa H Roberts, Dennis W Raisch, Todd A Thompson, Amy Bachyrycz, Matthew E Borrego
Publikováno v:
Personalized Medicine. 19:535-548
Aim: To elicit preferences for pharmacogenomic (PGx) testing in polypharmacy patients. Materials & methods: A face-to-face discrete choice experiment survey was designed and administered to adult polypharmacy patients recruited at a local retail phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc2b973c4b8feb96cad4376752b319eb
https://doi.org/10.2217/pme-2022-0056
https://doi.org/10.2217/pme-2022-0056
Autor:
Dennis W. Raisch, Rasha M. Arabyat, JA Rafi, Melanie A. Dodd, Sarrah N. Babb, Bernadette Jakeman
Publikováno v:
Currents in Pharmacy Teaching and Learning. 12:817-826
Introduction The purpose of this study was to evaluate whether a public health (PH) micro-level case-based learning exercise increased pharmacy students' self-perceived understanding and confidence in their role as PH pharmacists. Methods Three PH mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5633954fb2f4c7db807c50771140f794
https://doi.org/10.1016/j.cptl.2020.02.004
https://doi.org/10.1016/j.cptl.2020.02.004
Autor:
James O. Armitage, Shamia Hoque, Laura Rose Bobolts, LeAnn B. Norris, Sumimasa Nagai, Chadi Nabhan, Oliver Sartor, Anuhya Kommalapati, Robert C. Kane, Carlo DeAngelis, Paul R. Yarnold, Charles L. Bennett, Joshua Riente, Dennis W. Raisch, Brian Chen, Paul Ray, Ashley Caitlin Godwin, Stefano Luminari, William J. M. Hrushesky, Bryan L. Love, Bartlett J. Witherspoon, Kevin B. Knopf, Y. Tony Yang, Sri Harsha Tella
Publikováno v:
The Oncologist. 24:537-548
Biosimilar filgrastims are primarily indicated for chemotherapy-induced neutropenia prevention. They are less expensive formulations of branded filgrastim, and biosimilar filgrastim was the first biosimilar oncology drug administered in European Unio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a91efaecb4d6f230b29e040c3e43cbb8
https://doi.org/10.1634/theoncologist.2018-0341
https://doi.org/10.1634/theoncologist.2018-0341
Autor:
Rasha M. Arabyat, Dennis W. Raisch
Publikováno v:
Annals of Behavioral Medicine. 53:918-927
Background Patients with chronic obstructive pulmonary diseases (COPD) suffer from impaired Health-Related Quality of Life (HRQoL). Having an adequate social/emotional support may improve the quality of life of COPD patients. Objective To study the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea094c0131c3292564bb05ef3001d97
https://doi.org/10.1093/abm/kaz002
https://doi.org/10.1093/abm/kaz002
Autor:
Cynthia Maxwell, Mary Alore, Dana Rosson, Saville Kellner, Dinesh Khanna, Veronica J. Berrocal, Josephine Battyany, Janet L. Poole, Dennis W. Raisch, Jennifer Serrano, Sharon L. Newbill, Richard M. Silver, Laura Dyas, Pedro Cuencas, Luke Evnin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36844bf1e8ccc079bc5508b828d01b5a
https://doi.org/10.25302/04.2020.cer.131008323
https://doi.org/10.25302/04.2020.cer.131008323
Publikováno v:
Research in Social and Administrative Pharmacy. 14:162-169
Background Influenza virus is responsible for substantial morbidity and mortality. Specific populations are at higher risk for exacerbations from influenza virus, such as patients with chronic obstructive pulmonary disease (COPD). Influenza vaccinati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65926d2ed031e5b5b3000a4f1dd470a1
https://doi.org/10.1016/j.sapharm.2017.02.010
https://doi.org/10.1016/j.sapharm.2017.02.010
Autor:
Paul Ray, LeAnn B. Norris, Paul R. Yarnold, William J. M. Hrushesky, Charles L. Bennett, Joseph R. Berger, Robert C. Kane, Oliver Sartor, Rachel A. Sabol, Peter Georgantopoulos, Dennis W. Raisch, Laura Rose Bobolts, Akida Lebby, Zaina P. Qureshi, Virginia Noxon
Publikováno v:
Cancer Medicine
A 43‐year‐old female with multiple sclerosis developed urethral melanoma. The only potential risk factor was treatment with natalizumab, a humanized monoclonal antibody against α4 integrins. To investigate the risk‐exposure relationship, we re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d5a576b11cfe0f7c00a1ccf92d2db5
https://doi.org/10.1002/cam4.1098
https://doi.org/10.1002/cam4.1098
Publikováno v:
Expert opinion on drug safety. 18(8)
Objectives: To examine agreement between the FDA Adverse Event Reporting System (FAERS) and observational studies in common infections for tumor necrosis factor inhibitors (TNFi’s).Methods: Using M...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dade11bee9352e481e968907b11a33f
https://pubmed.ncbi.nlm.nih.gov/31173698
https://pubmed.ncbi.nlm.nih.gov/31173698
Autor:
Pedro Cuencas, Janet L. Poole, Dinesh Khanna, Anjali Sachdeva, Jody J. Fisher, Robert Riggs, Laura Dyas, Dennis W. Raisch, Luke Evnin, Veronica J. Berrocal, Saville Kellner, Mary Alore, Cynthia Maxwell, Sharon L. Newbill, Jennifer Serrano, Josephine Battyany, Erica Bush, Kerri Connolly, Richard M. Silver
Objective In a pilot study, our group showed that an internet-based self-management program improves self-efficacy in systemic sclerosis (SSc). The objective of the current study was to compare an internet-based self-management program to a patient-f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e7a60dccaac2c3079b4cd0e3b1c3be
https://europepmc.org/articles/PMC6226368/
https://europepmc.org/articles/PMC6226368/
Autor:
Oliver Sartor, Peter Georgantopoulos, Charles L. Bennett, William J. M. Hrushesky, LeAnn B. Norris, Dennis W. Raisch, Brian Chen, Akida Lebby, Robert C. Kane, Sumimasa Nagai, Terhi Hermanson, Y. Tony Yang, Laura R. Bobolts, Samuel Kessler, Joshua J. Riente, Zaina P. Qureshi, James O. Armitage
Publikováno v:
The Lancet Oncology. 17:e493-e501
Although the availability of generic oncology drugs allows access to contemporary care and reduces costs, there is international variability in the safety of this class of drugs. In this Series paper, we review clinical, policy, safety, and regulator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67bf860d2ec67972dc96835c876c2829
https://doi.org/10.1016/s1470-2045(16)30384-9
https://doi.org/10.1016/s1470-2045(16)30384-9